Physician profile
Mitchell R Harper
NPI 1205270360
$1,370.46
in general payments reported to CMS, 2019-2025
11 companies · $68.67 in 2025
The $68.67 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $949 · 2020: $25.82 · 2021: $54.68 · 2022: $165 · 2023: $70.96 · 2024: $36.21 · 2025: $68.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137 · Education: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.38 |
| Education | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $885.00 | 2019 | |
| Keystone Dental INC. | $156.21 | 2022-2023 | |
| Patterson Companies, INC. | $74.25 | 2023-2025 | |
| Dentsply Sirona INC | $64.84 | 2021-2023 | Endo Activator |
| Hu-Friedy Mfg. Co., LLC | $64.39 | 2019 | |
| Solventum Corporation | $36.06 | 2025 | 3m Scotchbond, 3m Clinpro |
| Align Technology, INC. | $29.58 | 2021 | |
| 3m Company | $25.82 | 2020 | |
| Gc America INC. | $13.90 | 2022 | |
| National Dentex LLC | $12.50 | 2021 | |
| Ultradent Products INC | $7.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.